EligibleTrials

Clinical trials recruiting for Advanced Microsatellite Stable Colorectal Carcinoma

Fewer than 3 recruiting trials found.

1
Recruiting trials
9
US states with sites
1
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 1Phase 2 1

Drugs and treatments being studied

InterventionTrials
Temozolomide1
Tuvusertib1

Where trials are recruiting (top US states)

StateRecruiting trials
California1
Connecticut1
Illinois1
Kansas1
Maryland1
Missouri1
Oklahoma1
Pennsylvania1
Tennessee1

Top cities

Bethesda, Maryland 1City of Saint Peters, Missouri 1Creve Coeur, Missouri 1Fairway, Kansas 1Irvine, California 1Kansas City, Kansas 1Kansas City, Missouri 1La Jolla, California 1Lee's Summit, Missouri 1Nashville, Tennessee 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Advanced Microsatellite Stable Colorectal Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Stage IV Colorectal Cancer AJCC v8 21Stage III Colorectal Cancer AJCC v8 10Metastatic Microsatellite Stable Colorectal Carcinoma 3Metastatic Malignant Solid Neoplasm 21Hematopoietic and Lymphatic System Neoplasm 9Colorectal cancer 1359Advanced Malignant Solid Neoplasm 13

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Advanced Microsatellite Stable Colorectal Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.